Polio Vaccine 2019 Global Trends, Market Size, Share, Status, Segmentation, SWOT Analysis and Forecast to 2024

“Polio Vaccine Market”
WiseGuyRerports.com Presents “Global Polio Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024” New Document to its Studies Database

 

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

Scope of the Report: 
The global average price of Polio Vaccine is in the increasing trend, from 497 USD/K doses in 2012 to 534 USD/K doses in 2016. With the situation of global economy and the IPV more and more popular, prices will be in increasing trend in the following five years. 
The classification of Polio Vaccine includes Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV), and the revenue proportion of Inactivated Polio Vaccine (IPV) in 2016 is about 15.4%, and the proportion is in decreasing trend from 2012 to 2016. 
The worldwide market for Polio Vaccine is expected to grow at a CAGR of roughly 5.0% over the next five years, will reach 1630 million US$ in 2024, from 1210 million US$ in 2019, according to a new GIR (Global Info Research) study. 
This report focuses on the Polio Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers 
Sanofi 
GSK 
Bibcol 
Serum Institute 
Tiantan Biological 
IMBCA 
Panacea Biotec Ltd 
Bio-Med 
Halfkin Bio-Pharmaceuticals

 

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3735289-global-polio-vaccine-market-2019-by-manufacturers-regions                          

                                     

Market Segment by Regions, regional analysis covers 
North America (United States, Canada and Mexico) 
Europe (Germany, France, UK, Russia and Italy) 
Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 
South America (Brazil, Argentina, Colombia etc.) 
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers 
Inactivated Polio Vaccine (IPV) 
Oral Polio Vaccine (OPV)

Market Segment by Applications, can be divided into 
Public 
Private

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3735289-global-polio-vaccine-market-2019-by-manufacturers-regions                 

 

Table Of Contents:      

1 Market Overview 
1.1 Polio Vaccine Introduction 
1.2 Market Analysis by Type 
1.2.1 Inactivated Polio Vaccine (IPV) 
1.2.2 Oral Polio Vaccine (OPV) 
1.3 Market Analysis by Applications 
1.3.1 Public 
1.3.2 Private 
1.4 Market Analysis by Regions 
1.4.1 North America (United States, Canada and Mexico) 
1.4.1.1 United States Market States and Outlook (2014-2024) 
1.4.1.2 Canada Market States and Outlook (2014-2024) 
1.4.1.3 Mexico Market States and Outlook (2014-2024) 
1.4.2 Europe (Germany, France, UK, Russia and Italy) 
1.4.2.1 Germany Market States and Outlook (2014-2024) 
1.4.2.2 France Market States and Outlook (2014-2024) 
1.4.2.3 UK Market States and Outlook (2014-2024) 
1.4.2.4 Russia Market States and Outlook (2014-2024) 
1.4.2.5 Italy Market States and Outlook (2014-2024) 
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 
1.4.3.1 China Market States and Outlook (2014-2024) 
1.4.3.2 Japan Market States and Outlook (2014-2024) 
1.4.3.3 Korea Market States and Outlook (2014-2024) 
1.4.3.4 India Market States and Outlook (2014-2024) 
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 
1.4.4 South America, Middle East and Africa 
1.4.4.1 Brazil Market States and Outlook (2014-2024) 
1.4.4.2 Egypt Market States and Outlook (2014-2024) 
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 
1.4.4.4 South Africa Market States and Outlook (2014-2024) 
1.4.4.5 Turkey Market States and Outlook (2014-2024) 
1.5 Market Dynamics 
1.5.1 Market Opportunities 
1.5.2 Market Risk 
1.5.3 Market Driving Force 

2 Manufacturers Profiles 
2.1 Sanofi 
2.1.1 Business Overview 
2.1.2 Polio Vaccine Type and Applications 
2.1.2.1 Product A 
2.1.2.2 Product B 
2.1.3 Sanofi Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.2 GSK 
2.2.1 Business Overview 
2.2.2 Polio Vaccine Type and Applications 
2.2.2.1 Product A 
2.2.2.2 Product B 
2.2.3 GSK Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.3 Bibcol 
2.3.1 Business Overview 
2.3.2 Polio Vaccine Type and Applications 
2.3.2.1 Product A 
2.3.2.2 Product B 
2.3.3 Bibcol Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.4 Serum Institute 
2.4.1 Business Overview 
2.4.2 Polio Vaccine Type and Applications 
2.4.2.1 Product A 
2.4.2.2 Product B 
2.4.3 Serum Institute Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.5 Tiantan Biological 
2.5.1 Business Overview 
2.5.2 Polio Vaccine Type and Applications 
2.5.2.1 Product A 
2.5.2.2 Product B 
2.5.3 Tiantan Biological Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.6 IMBCA 
2.6.1 Business Overview 
2.6.2 Polio Vaccine Type and Applications 
2.6.2.1 Product A 
2.6.2.2 Product B 
2.6.3 IMBCA Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.7 Panacea Biotec Ltd 
2.7.1 Business Overview 
2.7.2 Polio Vaccine Type and Applications 
2.7.2.1 Product A 
2.7.2.2 Product B 
2.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 

 Continued…….                                                      

 

Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com